Location History:
- Lima, NY (US) (2001 - 2005)
- Wilmington, DE (US) (2004 - 2008)
Company Filing History:
Years Active: 2001-2008
Title: David Gurley: Innovator in Nicotinic Receptor Modulation
Introduction
David Gurley is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate nicotinic receptors. With a total of 6 patents to his name, Gurley's work has the potential to impact therapeutic approaches for various conditions.
Latest Patents
Gurley's latest patents focus on positive modulators of nicotinic receptor agonists. One of his patents describes compounds according to a specific formula, which includes enantiomers and pharmaceutically acceptable salts. These compounds are designed to enhance the efficacy of agonists at nicotinic receptors, particularly for treating conditions associated with reductions in nicotinic transmission. Another patent outlines similar compounds, emphasizing their therapeutic applications and processes for preparation.
Career Highlights
Throughout his career, David Gurley has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Astra AB. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Gurley has collaborated with notable colleagues such as James Rosamond and Thomas Lanthorn. These partnerships have likely enriched his research and development efforts in the field of nicotinic receptor modulation.
Conclusion
David Gurley's innovative work in the modulation of nicotinic receptors showcases his commitment to advancing therapeutic options in pharmacology. His contributions through patents and collaborations highlight the importance of innovation in addressing medical challenges.